Abstract | PURPOSE: METHODS: RESULTS: The median of total OMAS score was statistically significant lower in patients who received benzydamine HCl during concurrent chemo- radiotherapy (CCRT) than in those who received sodium bicarbonate, (p value < 0.001). There was no difference in median pain score, (p value = 0.52). Nineteen percent of patients in sodium bicarbonate arm needed oral antifungal agents whereas none in the benzydamine HCl arm required such medications, (p value = 0.06). Tube feeding needs and the compliance of CCRT were not different between the two study arms. CONCLUSIONS:
|
Authors | Imjai Chitapanarux, Tharatorn Tungkasamit, Janjira Petsuksiri, Danita Kannarunimit, Kanyarat Katanyoo, Chakkapong Chakkabat, Jiraporn Setakornnukul, Somying Wongsrita, Naruemon Jirawatwarakul, Chawalit Lertbusayanukul, Patumrat Sripan, Patrinee Traisathit |
Journal | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
(Support Care Cancer)
Vol. 26
Issue 3
Pg. 879-886
(Mar 2018)
ISSN: 1433-7339 [Electronic] Germany |
PMID | 28942587
(Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial)
|
Chemical References |
- Anti-Inflammatory Agents
- Benzydamine
- Sodium Bicarbonate
|
Topics |
- Adolescent
- Adult
- Aged
- Anti-Inflammatory Agents
(administration & dosage, pharmacology, therapeutic use)
- Benzydamine
(administration & dosage, pharmacology, therapeutic use)
- Double-Blind Method
- Female
- Humans
- Male
- Middle Aged
- Radiation Injuries
(drug therapy)
- Sodium Bicarbonate
(administration & dosage, pharmacology, therapeutic use)
- Stomatitis
(drug therapy)
- Young Adult
|